ClassID:

20523

A61K31/7048 - page 10 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Recent Application in this class:
#2701
20150126467
2015-05-07

USE OF ALGINATE OLIGOMERS TO ENHANCE THE EFFECTS OF ANTIFUNGAL AGENTS

#2702
20150126465
2015-05-07

PROCESS FOR PRODUCING DERIVATIVES OF PYROSTEGIA VENUSTA, DERIVATIVES OF PYROSTEGIA VENUSTA, PHARMACEUTICAL COMPOSITIONS AND ITS USES

#2703
20150126464
2015-05-07

THERAPEUTIC DRUG AND THERAPEUTIC METHOD FOR NEUROLOGICAL DISEASES INCLUDING ALZHEIMER'S DISEASE ASSOCIATED WITH 1,25D3-MARRS

#2704
20150119348
2015-04-30

CDK5 inhibitors and therapeutic uses thereof

#2705
20150119347
2015-04-30

Composition for preventing or treating hair loss or promoting hair growth comprising secoiridoid glucoside derivatives

#2706
20150119322
2015-04-30

NUTRITIONAL COMPOSITIONS CONTAINING A PREBIOTIC AND LACTOFERRIN AND USES THEREOF

#2707
20150118289
2015-04-30

Nanoparticle, method of preparating the same, and use of the nanoparticle

#2708
20150111845
2015-04-23

Methods for treating gastrointestinal diseases

#2709
20150111844
2015-04-23

Polyphenol composition

#2710
20150111832
2015-04-23

Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs

#2711
20150111826
2015-04-23

Acylated glucagon analogues

#2712
20150110847
2015-04-23

Substrate Mediated Enzymes Prodrug Therapy

#2713
20150110838
2015-04-23

Therapeutic combinations for treating Johne's disease

#2714
20150110767
2015-04-23

Methods for treating lung infections and inflammation

#2715
20150105339
2015-04-16

Methods for treating resistant diseases using triazole containing macrolides

#2716
20150105338
2015-04-16

THERAPEUTIC COMPOSITIONS COMPRISING PHENOLIC ACIDS FOR TREATING CONDITIONS RELATED TO INAPPROPRIATE PLATELET AGGREGATION

#2717
20150105330
2015-04-16

Active mixtures of acylated oligopeptides and troxerutin

#2718
20150104382
2015-04-16

Compositions and methods for identifying and targeting cancer cells of alimentary canal origin

#2719
20150099789
2015-04-09

Use of Odiparcil in the treatment of a mucopolysaccharidosis

#2720
20150099712
2015-04-09

Method and compounds for inhibiting the MCM complex and their application in cancer treatment

#2721
20150094335
2015-04-02

Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent

#2722
20150093455
2015-04-02

COMPOSITIONS AND METHODS FOR INCREASING TELOMERASE ACTIVITY

#2723
20150087886
2015-03-26

NOVEL BIFUNCTIONAL METNASE/INTNASE INHIBITORS AND RELATED COMPOSITIONS AND METHODS OF TREATMENT OF CANCER

#2724
20150087608
2015-03-26

Methods and devices for treating conditions associated with autonomic dysfunction

#2725
20150086662
2015-03-26

extract comprising flavonoids in cosmetic and pharmaceutical compositions

#2726
20150086655
2015-03-26

Morinda Citrifolia Juice Formulations Comprising Iridoids

#2727
20150080327
2015-03-19

Targeted Osmotic Lysis of Cancer Cells

#2728
20150079060
2015-03-19

Nutritional supplement

#2729
20150079029
2015-03-19

METHODS AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS

#2730
20150065441
2015-03-05

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF COGNITIVE FUNCTION DISORDERS COMPRISING SPINOSYN

#2731
20150065438
2015-03-05

Prepackaged sterile syringe or containers with various substance concentrations with or without bioactive reagent

#2732
20150064287
2015-03-05

METHOD FOR TREATING ABNORMAL POLYGLUTAMINE-MEDIATED DISEASES

#2733
20150064223
2015-03-05

Biguanide compositions and methods of treating metabolic disorders

#2734
20150057239
2015-02-26

Solid oral pharmaceutical compositions for isoxazoline compounds

#2735
20150056292
2015-02-26

Joint product comprising synephrine and topiramate

#2736
20150056270
2015-02-26

Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside

#2737
20150051245
2015-02-19

Kinase protein binding inhibitors

#2738
20150050367
2015-02-19

Timosaponin compounds

#2739
20150045337
2015-02-12

Controlled release compositions and their methods of use

#2740
20150045315
2015-02-12

Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound

#2741
20150044308
2015-02-12

Pharmaceutical composition for treating urinary incontinence and enuresis

#2742
20150044297
2015-02-12

Galenical system for active transport, method for preparation and use

#2743
20150044173
2015-02-12

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#2744
20150038565
2015-02-05

Long acting compositions

#2745
20150038441
2015-02-05

Kit-in-parts for cleaning and treating ears of companion animals

#2746
20150038406
2015-02-05

Pharmaceutical formulations of tranexamic acid and their use

#2747
20150037396
2015-02-05

Targeting delivery of anti-fungal agents

#2748
20150031640
2015-01-29

Antibacterial agents: combination of a rifamycin and a switch region inhibitor

#2749
20150031639
2015-01-29

C-glycosylpolyphenol antidiabetic agents, effect on glucose tolerance and interaction with beta-amyloid. therapeutic applications of the synthesized agent(s) and of ethyl acetate extracts containing some of those agents

#2750
20150030701
2015-01-29

Antimicrobial compositions and methods

#2751
20150025027
2015-01-22

Combination of a Monosubstituted Sulfamate Derivate of the Natural Monosaccharide d-Fructose (Topiramate) with an Anti-Depressant from the Phenyl Ketone Class (Bupropion) for Treating Obesity and Plurimetabolic Syndromes

#2752
20150025025
2015-01-22

Immuno-modulators for treating functional epithelial syndromes

#2753
20150023915
2015-01-22

Treatment for melanoma

#2754
20150023905
2015-01-22

Synthetic mechanical hemostatic composition, method of making and use thereof

#2755
20150018906
2015-01-15

Paeoniflorin preparations and uses thereof for fat reduction

#2756
20150018391
2015-01-15

Animal treatments

#2757
20150018293
2015-01-15

Animal treatments

#2758
20150017264
2015-01-15

Procaspase 3 activation by combination therapy

#2759
20150011491
2015-01-08

Treatment of papulopustular rosacea with ivermectin

#2760
20150011490
2015-01-08

Treatment of papulopustular rosacea with ivermectin

#2761
20150011489
2015-01-08

Treatment of inflammatory lesions of rosacea with ivermectin

#2762
20150010645
2015-01-08

Tannin formulation for treating malnutrition

#2763
20150010638
2015-01-08

Method for improving water solubility of slightly soluble substance

#2764
20150010626
2015-01-08

Escalating dosing regimen for effecting weight loss and treating obesity

#2765
20150010625
2015-01-08

Low dose topiramate/phentermine composition and methods of use thereof

#2766
20140378398
2014-12-25

PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS

#2767
20140377293
2014-12-25

Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone

#2768
20140371164
2014-12-18

Synergistic combination comprising avermectins and a NSAID for tumor inhibition

#2769
20140371134
2014-12-18

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

#2770
20140370134
2014-12-18

Composition comprising and and for treating neurodegenerative diseases

#2771
20140370122
2014-12-18

Methods and compositions for promoting activity of anti-cancer therapies

#2772
20140364385
2014-12-11

Forazolines, compositions thereof and uses thereof

#2773
20140364383
2014-12-11

Methods and compositions for applying pharmacologic agents to the ear

#2774
20140364382
2014-12-11

Composition for inhibiting liver function deterioration, containing citrus peel extract or narirutin as active ingredient, and method for extracting narirutin from citrus peel

#2775
20140364373
2014-12-11

Methods for treating gastrointestinal disorders associated with Parkinson's disease, autism, diabetic gastroparesis

#2776
20140363506
2014-12-11

FORMULATION FOR PULMONARY ADMINISTRATION OF ANTIFUNGAL AGENTS, AND ASSOCIATED METHODS OF MANUFACTURE AND USE

#2777
20140357586
2014-12-04

Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions

#2778
20140357583
2014-12-04

Sugar extracts

#2779
20140357580
2014-12-04

ANTI-MICROBIAL COMPOSITIONS

#2780
20140356456
2014-12-04

Treating cancer with ATR inhibitors

#2781
20140356334
2014-12-04

Methods for improved wound closure employing olivamine and endothelial cells

#2782
20140349953
2014-11-27

MAILLARD REACTION INHIBITOR

#2783
20140348966
2014-11-27

GARCINIA BUCHANANII BAKER COMPOUNDS, COMPOSITIONS AND RELATED METHODS

#2784
20140348965
2014-11-27

Use of a flavanol glycoside for suppressing activation of stellate cells

#2785
20140348922
2014-11-27

Process for producing a particulate composition comprising an hydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid

#2786
20140343116
2014-11-20

CYTOCHROME P450 2C9 INHIBITORS

#2787
20140343004
2014-11-20

Compositions for oral administration to animals, processes for obtaining the same and the uses thereof

#2788
20140343002
2014-11-20

Method of lowering glycemic index of foods

#2789
20140341815
2014-11-20

Delivery system for remote treatment of an animal

#2790
20140336139
2014-11-13

TOPICAL APPLICATION OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS/AFFLICTIONS

#2791
20140336138
2014-11-13

COMPOSITIONS AND METHODS FOR SCREENING AND TREATMENT OF STURGE-WEBER SYNDROME, KLIPPEL-TRENAUNAY-WEBER SYNDROME, AND PORT-WINE STAINS (PWSS)

#2792
20140335211
2014-11-13

Use of neohesperidin

#2793
20140335152
2014-11-13

Methods and compositions for enhancing the uptake of therapeutic agents by target cells

#2794
20140329767
2014-11-06

Methods for treating type-2 diabetes and obesity

#2795
20140328917
2014-11-06

Organic compound nano-powder, method for producing the same and suspension

#2796
20140328911
2014-11-06

COMPOSITIONS COMPRISING POMEGRANATE POLYPHENOLS IN COMBINATION WITH ERECTILE DYSFUNCTION-TREATING COMPOUNDS, AND METHODS OF TREATING ERECTILE DYSFUNCTION THEREWITH

#2797
20140328902
2014-11-06

Antimicrobials and methods of use thereof for wound healing

#2798
20140328863
2014-11-06

Induction of differential stress resistance and uses thereof

#2799
20140323507
2014-10-30

Mycophenolic acid analogues as anti-tumor chemosensitizing agents

#2800
20140323419
2014-10-30

HIGH EFFICACY COMBINATION THERAPY FOR HELICOBACTER PYLORI ERADICATION AND PACKAGING FOR THE DISTRIBUTION AND USE THEREOF

#2801
20140323399
2014-10-30

Compositions and methods for increasing insulin sensitivity

#2802
20140322368
2014-10-30

METHOD OF REDUCING AND IMPROVING THE APPEARANCE OF SCAR TISSUE

#2803
20140322343
2014-10-30

Sustained-release formulations of topiramate

#2804
20140322293
2014-10-30

Methods for treating conditions of the nail unit

#2805
20140322208
2014-10-30

Treatment of hematologic malignancies with an anti-CXCR4 antibody

#2806
20140322198
2014-10-30

COMPOSITION COMPRISING VICENIN-2 HAVING A BENEFICIAL EFFECT ON NEUROLOGICAL AND/OR COGNITIVE FUNCTION

#2807
20140315842
2014-10-23

Avermectins and milbemycins as anti-mycobacterial agents

#2808
20140315841
2014-10-23

Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof

#2809
20140315832
2014-10-23

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#2810
20140314888
2014-10-23

Anti-inflammatory composition comprising malvidin-3-O-β-glucoside and a propolis extract

#2811
20140309181
2014-10-16

Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small molecules

#2812
20140308344
2014-10-16

Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation

#2813
20140308339
2014-10-16

Lipophilic drug delivery vehicle and methods of use thereof

#2814
20140303105
2014-10-09

Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens

#2815
20140303103
2014-10-09

Carbonic anhydrase IX-related markers and use thereof

#2816
20140303097
2014-10-09

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#2817
20140302088
2014-10-09

Compositions and methods for dengue virus chimeric constructs in vaccines

#2818
20140296141
2014-10-02

Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus

#2819
20140296135
2014-10-02

MEDICAMENT FOR THE TREATMENT OF FUNGAL INFECTIONS PARTICULARLY ASPERGILLOSIS

#2820
20140295009
2014-10-02

COMPOSITION AND METHOD FOR BOOSTING IMMUNOLOGICAL RESPONSE

#2821
20140294787
2014-10-02

Extensional viscosity to promote safe swallowing of food boluses

#2822
20140288023
2014-09-25

Cyclodextrin-based polymers for therapeutics delivery

#2823
20140288016
2014-09-25

Method of providing an anti-ulcer treatment with extracts and isolated flavonoids from

#2824
20140288015
2014-09-25

METHODS AND DEVICES FOR AFFECTING NERVE FUNCTION

#2825
20140287074
2014-09-25

Extracts of deschampsia antartica with antineoplastic activity

#2826
20140287047
2014-09-25

Nanoemulsion therapeutic compositions and methods of using the same

#2827
20140286928
2014-09-25

Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

#2828
20140274936
2014-09-18

Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients

#2829
20140271944
2014-09-18

Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal

#2830
20140271902
2014-09-18

Particulate hyaluronic acid and flavonoid formulations for cellular delivery of bioactive agents

#2831
20140271839
2014-09-18

Extended-release topiramate capsules

#2832
20140271777
2014-09-18

Anti-biofilm compositions and methods for using

#2833
20140271701
2014-09-18

USE OF MYCOBACTERIUM AVIUM PARATUBERCULOSIS PEPTIDES TO DIAGNOSE TYPE 1 DIABETES

#2834
20140271561
2014-09-18

Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens

#2835
20140256663
2014-09-11

Amphotericin Analogous Compounds and Pharmaceutical Compositions Containing Them

#2836
20140256662
2014-09-11

Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies

#2837
20140256661
2014-09-11

PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION

#2838
20140256624
2014-09-11

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#2839
20140256619
2014-09-11

Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones

#2840
20140256616
2014-09-11

MODIFIED GREEN TEA POLYPHENOL FORMULATIONS

#2841
20140255511
2014-09-11

Accelerating muscle recovery after immobilization-induced muscle atrophy

#2842
20140249096
2014-09-04

COMBINATION OF COMPOUNDS FOR TREATING OR PREVENTING SKIN DISEASES

#2843
20140249095
2014-09-04

Method for Inhibiting Spinocerebellar Ataxia

#2844
20140243284
2014-08-28

Biologically active macrolides, compositions, and uses thereof

#2845
20140243279
2014-08-28

Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

#2846
20140242204
2014-08-28

Pharmaceutical composition for preventing or treating diabetic erectile dysfunction comprising C3G or extract of mulberry containing C3G

#2847
20140242176
2014-08-28

Compositions, methods, and devices for the treatment of eye stain

#2848
20140242153
2014-08-28

Encochleation methods, cochleates and methods of use

#2849
20140242051
2014-08-28

Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof

#2850
20140241998
2014-08-28

Foamable carriers

#2851
20140235590
2014-08-21

Pharmaceutical compounds for use in the therapy of infection

#2852
20140228309
2014-08-14

STABILIZED FORMULATION FOR ORAL ADMINISTRATION OF THERAPEUTIC AGENTS AND RELATED METHODS

#2853
20140228308
2014-08-14

FORMULATIONS FOR THE ORAL ADMINISTRATION OF THERAPEUTIC AGENTS AND RELATED METHODS

#2854
20140228307
2014-08-14

Composition and method for treating an autoimmune disease

#2855
20140228303
2014-08-14

NOVEL SGLT INHIBITORS

#2856
20140227239
2014-08-14

GROWTH HORMONE SECRETAGOGUE

#2857
20140221299
2014-08-07

Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation

#2858
20140220165
2014-08-07

Compositions for the treatment of peripheral ulcers of various origins

#2859
20140220109
2014-08-07

NOVEL COCHLEATE FORMULATIONS

#2860
20140220108
2014-08-07

COCHLEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME

#2861
20140220006
2014-08-07

LUNG CANCER BIOMARKERS

#2862
20140219965
2014-08-07

Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance

#2863
20140219960
2014-08-07

Composition for treating hepatitis C virus, regulating phosphorylation of replicase

#2864
20140212504
2014-07-31

Phospholipid-based powders for drug delivery

#2865
20140212490
2014-07-31

TABLET FOR PULSED DELIVERY

#2866
20140212463
2014-07-31

Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof

#2867
20140206724
2014-07-24

Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent

#2868
20140206723
2014-07-24

Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione

#2869
20140206637
2014-07-24

Inhibition of nonsense mediated mRNA decay by drugs that prevent hypusination of eukaryotic initiation factor 5A

#2870
20140206631
2014-07-24

Cardiac Glycoside Analogs in Combination with Emodin for Cancer Therapy

#2871
20140200199
2014-07-17

Compositions and methods for treatment of cancer

#2872
20140200194
2014-07-17

Use of uraria in promoting osteogenesis or providing neuroprotection

#2873
20140200189
2014-07-17

Artonin I to treat resistant infectious

#2874
20140199391
2014-07-17

Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compound

#2875
20140199291
2014-07-17

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)

#2876
20140194375
2014-07-10

Topical antibiotic composition for the prevention of lyme disease

#2877
20140194374
2014-07-10

Anthelmintic Formulations and Treatments

#2878
20140194373
2014-07-10

COSMETIC USE OF HESPERIDIN OR A DERIVATIVE THEREOF IN THE PREVENTION AND/OR TREATMENT OF BODY ODOUR

#2879
20140194372
2014-07-10

Heart failure suppressing agent

#2880
20140193530
2014-07-10

Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug

#2881
20140193519
2014-07-10

INDIBULIN THERAPY

#2882
20140193513
2014-07-10

Method for solubilising, dispersing and stabilising of substances, products manufactured according to the method as well as the use thereof

#2883
20140193479
2014-07-10

Topical treatment of keratotic lesions using hamelia patens

#2884
20140193436
2014-07-10

EXTRACELLULAR TARGETED DRUG CONJUGATES

#2885
20140187623
2014-07-03

Escalating dosing regimen for effecting weight loss and treating obesity

#2886
20140187505
2014-07-03

Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders

#2887
20140186430
2014-07-03

Cochleate compositions directed against expression of proteins

#2888
20140186404
2014-07-03

Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies

#2889
20140178943
2014-06-26

Process for producing a particulate composition comprising anhydrous crystalline 2-O-alpha-D-glucosyl-L-ascorbic acid

#2890
20140178494
2014-06-26

Methods of treating gastrointestinal spasms in a subject having diverticulitis

#2891
20140175330
2014-06-26

Methods for extraction of bioactive polyelectrolytes from humified organic materials

#2892
20140171380
2014-06-19

Methods of reducing levels of tau

#2893
20140170250
2014-06-19

Pharmaceutical compositions and method for inhibiting angiogenesis

#2894
20140170227
2014-06-19

Method for making nanolipidic particles

#2895
20140170226
2014-06-19

Method for making nanolipidic particles

#2896
20140162968
2014-06-12

METHOD FOR SCREENING OF AGENT FOR TREATING OR PREVENTING OBESITY

#2897
20140161747
2014-06-12

Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea

#2898
20140155341
2014-06-05

USE OF SS'-DIMETHYL-GLIOTOXIN AS DIAGNOSTIC MARKER OF PATHOLOGIES CAUSED BY GLIOTOXIN-PRODUCING FUNGI OR THEIR DERIVATIVES

#2899
20140155339
2014-06-05

Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition

#2900
20140155338
2014-06-05

Use of pimobendan for the reduction of heart size in mammals suffering from heart failure

#2901
20140155336
2014-06-05

Water-soluble camptothecin derivative, pharmaceutical composition and use thereof

#2902
20140154317
2014-06-05

Pharmaceutical Composition for Treatment of Helicobacter Pylori Associated Diseases

#2903
20140148409
2014-05-29

Fluid for peritoneal dialysis

#2904
20140148402
2014-05-29

Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome

#2905
20140148400
2014-05-29

CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY

#2906
20140148399
2014-05-29

Compositions and methods for treating or ameliorating obesity or for reducing diabetic hypercholesterolemia

#2907
20140147537
2014-05-29

FRUIT EXTRACTS

#2908
20140147492
2014-05-29

METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AGENTS BY TARGET CELLS

#2909
20140128583
2014-05-08

Erythromycin ethylsuccinate crystalline hydrate, preparation and uses thereof

#2910
20140128356
2014-05-08

Na/K-ATPase ligand

#2911
20140128336
2014-05-08

MEDICAL PRODUCTS FOR USE IN CONDITIONS RELATED TO MICROBIAL INFECTIONS IN THE UPPER AERODIGESTIVE TRACT

#2912
20140128335
2014-05-08

Use of polyaminoisoprenyl derivatives in antibiotic or antiseptic treatment

#2913
20140128333
2014-05-08

Compounds, Compositions, and Methods for Decreasing Intestinal Glucose Uptake and Inducing Incretin Release

#2914
20140127194
2014-05-08

COMBINED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS

#2915
20140121732
2014-05-01

Methods and compositions for administering a specific wavelength phototherapy

#2916
20140120191
2014-05-01

METHOD OF TREATING A DISORDER ASSOCIATED WITH SEQUESTERED BACTERIA

#2917
20140107391
2014-04-17

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

#2918
20140107317
2014-04-17

Selective targeting agents for mitochondria

#2919
20140107054
2014-04-17

Method of treating clostridium difficile-associated diarrhea

#2920
20140107053
2014-04-17

APPLES WITH HIGH POLYPHENOLIC CONTENT

#2921
20140107052
2014-04-17

Edible composition

#2922
20140107048
2014-04-17

Compositions containing phenolic compounds and hydrotropes for cosmetic use

#2923
20140107047
2014-04-17

Cosmetic compositions for increasing bioavailability of the active compounds baicalin and/or vitamin C

#2924
20140106003
2014-04-17

Thioxanthone-based autophagy inhibitor therapies to treat cancer

#2925
20140100181
2014-04-10

TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING A WATER-SENSITIVE ACTIVE PRINCIPLE

#2926
20140088027
2014-03-27

PHARMACEUTICAL COMPOSITION COMPRISING AN SGLT2 INHIBITOR AND A PPAR- GAMMA AGONIST AND USES THEREOF

#2927
20140088023
2014-03-27

sGCalphal inhibiting compositions

#2928
20140087943
2014-03-27

Pesticidal Active Mixtures Comprising Isoxazoline Compounds I

#2929
20140087000
2014-03-27

Method and System for Treatment of Biological Tissue

#2930
20140080779
2014-03-20

Macrocyclic lactones and use thereof

#2931
20140080778
2014-03-20

Use of secnidazole in treatment of dental infections

#2932
20140080776
2014-03-20

COMPOSITION AND METHODS FOR EXTRACTING AND USING PHYTOCHEMICALS FOR THE TREATMENT OF INFLUENZA

#2933
20140080775
2014-03-20

MOLECULAR MODULATORS OF THE WNT/BETA-CATENIN PATHWAY

#2934
20140080774
2014-03-20

Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors

#2935
20140080772
2014-03-20

TREATMENTS FOR MELANOMA

#2936
20140079834
2014-03-20

Bioactive fractions and compounds from for the prevention or treatment of osteo-health related disorders

#2937
20140079812
2014-03-20

Disulfide chemotherapeutic agents and methods of use thereof

#2938
20140073578
2014-03-13

Combination therapy with leukotoxin

#2939
20140072639
2014-03-13

Nanolipidic particle assembly populations

#2940
20140072620
2014-03-13

LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF

#2941
20140066623
2014-03-06

Ribosome structure and protein synthesis inhibitors

#2942
20140066392
2014-03-06

Combination treatments for melanoma

#2943
20140057860
2014-02-27

PHARMACEUTICAL COMPOSITION FOR TREATING CARDIOVASCULAR AND CEREBROVASCULAR DISEASES AND METHOD OF MANUFACTURING THE SAME

#2944
20140057853
2014-02-27

Compositions of A-8R peptide

#2945
20140057852
2014-02-27

Treatment of cancers with A-8R peptide

#2946
20140056844
2014-02-27

METHODS OF METABOLIC TARGETING CANCER CELLS USING CHEMO- AND IMMUNOTHERAPY FOR TREATING CANCER

#2947
20140051653
2014-02-20

Topical application of ivermectin for the treatment of dermatological conditions/afflictions

#2948
20140051652
2014-02-20

Treatment for Migraine Headache

#2949
20140051644
2014-02-20

Pharmaceutical composition for treating hyperproliferative diseases

#2950
20140045801
2014-02-13

PRAMIPEXOLE TRANSDERMAL DELIVERY FOR SEVERE HEADACHES

#2951
20140045765
2014-02-13

Method for inhibiting autophagy of motor neurons

#2952
20140044808
2014-02-13

Dietetic or pharmaceutical preparation containing tartary buckwheat

#2953
20140039070
2014-02-06

Compositions and methods of delivery of pharmacological agents

#2954
20140039069
2014-02-06

Compositions and methods of delivery of pharmacological agents

#2955
20140038913
2014-02-06

Luteolin and diosmin/diosmetin as novel STAT3 inhibitors for treating autism

#2956
20140038911
2014-02-06

Pharmaceutical composition, methods for treating and uses thereof

#2957
20140038888
2014-02-06

Pharmaceutical combinations for the treatment of metabolic disorders

#2958
20140038883
2014-02-06

NOVEL AZACOUMARIN DERIVATIVES HAVING MDR PUMP INHIBITING ACTIVITY

#2959
20140037770
2014-02-06

Burdock fruit extract containing arctigenin and method for producing same

#2960
20140031306
2014-01-30

Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad

#2961
20140024609
2014-01-23

Treatment of Bacterial Infections

#2962
20140023701
2014-01-23

Method and Composition for Ameliorating the Effects tor a Subject Exposed to Radiation or Other Sources of Oxidative Stress

#2963
20140018415
2014-01-16

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

#2964
20140018311
2014-01-16

Muscadine compositions with improved anti-oxidant activity

#2965
20140018310
2014-01-16

Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency

#2966
20140011756
2014-01-09

Method for Treatment of Inflammation

#2967
20140011755
2014-01-09

Cardiac Glycosides for Treating Autoimmune Disease

#2968
20140004212
2014-01-02

ANDROGRAPHIS PANICULATA EXTRACT

#2969
20140004093
2014-01-02

Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution

#2970
20130345158
2013-12-26

Composition for promoting hematogenesis containing quercetin 3-O-β-(2″-galloyl)-rhamnopyranoside as active ingredient

#2971
20130345146
2013-12-26

NEAR-INFRARED ELECTROMAGNETIC MODIFICATION OF CELLULAR STEADY-STATE MEMBRANE POTENTIALS

#2972
20130344174
2013-12-26

Bioactive Fractions and Compounds from Polygonum genus, their Use in Anti-diarrhea and the Method of Preparation

#2973
20130343995
2013-12-26

Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy

#2974
20130338089
2013-12-19

Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells

#2975
20130337092
2013-12-19

PHYTONUTRIENT COMPOSITIONS AND METHODS OF USE

#2976
20130337088
2013-12-19

Methods for treating scars and aging skin

#2977
20130336941
2013-12-19

LONG LASTING ABSORPTION OF FLAVONOIDS

#2978
20130331347
2013-12-12

Treatment of Clostridium Difficile Infection in Patients Undergoing Antibiotic Therapy

#2979
20130331345
2013-12-12

PUERARIN HYDRATES, PREPARATION METHODS AND USES THEREOF

#2980
20130331311
2013-12-12

Synergistic Combinations of Polyene Fungicides and Non-Ribosomal Peptides and Related Methods of Use

#2981
20130324487
2013-12-05

Cyanidin-3-glucoside and Methods for Using the Same

#2982
20130324485
2013-12-05

Method of Determining the Probability of a Therapeutic Response in Cancer Chemotherapy with Cardiac Glycoside

#2983
20130324464
2013-12-05

Aryl glycoside compound, preparation method and use thereof

#2984
20130317018
2013-11-28

Methods and compositions for unsilencing imprinted genes

#2985
20130316966
2013-11-28

Use of albiflorin and metabolites thereof

#2986
20130309225
2013-11-21

Combination of CD37 antibodies with ICE

#2987
20130303472
2013-11-14

Solid state forms of fidaxomycin and processes for preparation thereof

#2988
20130303470
2013-11-14

Plant extraction method and compositions

#2989
20130303468
2013-11-14

Vicenin 2 and analogues thereof for use as an antispasmodic and/or prokinetic agent

#2990
20130302449
2013-11-14

Method of treating neurological conditions with oleandrin-containing extract

#2991
20130296253
2013-11-07

Uses of an immunomodulatory protein (GMI) from

#2992
20130295207
2013-11-07

Skin whitening agent

#2993
20130295045
2013-11-07

Medicament comprising recombinant antibody against chemokine receptor CCR4

#2994
20130289095
2013-10-31

Synthetic lethality in cancer

#2995
20130288989
2013-10-31

NEW USE OF CHEMICAL INGREDIENTS IN CYNOMORIUM AS PHYTOESTROGEN

#2996
20130288956
2013-10-31

COMBINED PHARMACEUTICAL COMPOSITION AS ANTIFUNGAL AGENT

#2997
20130274216
2013-10-17

TREATMENT FOR MICROBE-INDUCED INFLAMMATORY RESPONSES IN THE EYE

#2998
20130274215
2013-10-17

PHARMACEUTICAL COMPOSITIONS TO TREAT FIBROSIS

#2999
20130274212
2013-10-17

Sesterterpene Compounds and Use Thereof

#3000
20130274175
2013-10-17

TREATMENT OF DISEASE ASSOCIATED WITH THE USE OF ANTIBIOTICS